Bien-Etre / Well Being

Vortioxetine: A Next-Generation Antidepressant


  Vortioxetine is a next-generation antidepressant with multimodal action. It was first approved in 2013. It’s a novel antidepressant with a unique profile. That’s because it acts as a multimodal serotonergic agent. Its efficacy in major depressive disorder has been established in both short-term and long-term studies. Furthermore, it’s able to modulate a wide range of neurotransmitters. For example, serotonin, dopamine, norepinephrine, histamine, glutamate, and GABA. Its side effects also differ from conventional antidepressants. In fact, it has low rates of the usual side effects of sexual dysfunction, weight gain, and cardiovascular disorders. Major depressive disorder (MDD) Major depressive disorder…

This content is for Q17c Membership, Classified Membership, and LifeTime Patriot Membership members only.
Login Join Now
Chantal Maille
Praticien en Psychothérapie - Psychanalyste, Coaching conjugal & Sophrologie

IDC Community Thought(s) – 2.4.22

Previous article

No Escape, No Deals, Clock Activated, Panic Mode – Ep. 2694

Next article

You may also like


Comments are closed.